Life Science Start-Ups: Tech Transfer Deals, July-August 2014
• By Deanna Kamienski, Beth Allan, Amanda Micklus, and Maureen Riordan
Derived from Strategic Transactions, a fully searchable premium source for tracking life sciences deal activity, the Tech Transfer Deals column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June 2014.
Fudan University’s Shanghai Medical College (SMC) licensed Inovio Pharmaceuticals Inc. (active immunotherapeutics delivered via electroporation technology) exclusive global...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
Natco to buy out Adcock Ingram’s minority shareholders in what’s possibly its biggest M&A investment, opening up substantial opportunities in South Africa and the region. If the offer goes through, it will result in the delisting of Adcock, with Bidvest and Natco co-owning the firm.
Scrip discusses the latest M&A activity and trends with CEO Shawn Titcomb of Allele Capital and Cheryl Reicin, a partner focused on international life sciences activity at Mintz.
